Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8598 |
High Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.8435 |
Intermediate Similarity |
NPD9360 |
Approved |
0.8393 |
Intermediate Similarity |
NPD9375 |
Discontinued |
0.8205 |
Intermediate Similarity |
NPD307 |
Approved |
0.8174 |
Intermediate Similarity |
NPD9374 |
Approved |
0.8 |
Intermediate Similarity |
NPD9373 |
Approved |
0.7983 |
Intermediate Similarity |
NPD9409 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD9607 |
Approved |
0.7815 |
Intermediate Similarity |
NPD9606 |
Approved |
0.7795 |
Intermediate Similarity |
NPD209 |
Clinical (unspecified phase) |
0.7699 |
Intermediate Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD237 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD515 |
Phase 1 |
0.7478 |
Intermediate Similarity |
NPD9291 |
Approved |
0.7442 |
Intermediate Similarity |
NPD545 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD547 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD1808 |
Phase 1 |
0.7328 |
Intermediate Similarity |
NPD194 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD9632 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD1121 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1120 |
Approved |
0.7273 |
Intermediate Similarity |
NPD252 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD582 |
Approved |
0.7154 |
Intermediate Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD1430 |
Approved |
0.7132 |
Intermediate Similarity |
NPD1431 |
Approved |
0.7121 |
Intermediate Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.7054 |
Intermediate Similarity |
NPD8838 |
Approved |
0.6934 |
Remote Similarity |
NPD549 |
Approved |
0.6742 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6723 |
Remote Similarity |
NPD341 |
Approved |
0.6723 |
Remote Similarity |
NPD340 |
Approved |
0.6713 |
Remote Similarity |
NPD775 |
Approved |
0.669 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD8954 |
Approved |
0.6667 |
Remote Similarity |
NPD8955 |
Approved |
0.6587 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.6583 |
Remote Similarity |
NPD8859 |
Approved |
0.6583 |
Remote Similarity |
NPD8861 |
Approved |
0.6583 |
Remote Similarity |
NPD8862 |
Approved |
0.6575 |
Remote Similarity |
NPD3086 |
Phase 3 |
0.6565 |
Remote Similarity |
NPD798 |
Discontinued |
0.6529 |
Remote Similarity |
NPD8836 |
Approved |
0.6515 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.6507 |
Remote Similarity |
NPD3085 |
Phase 1 |
0.6489 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.6466 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.646 |
Remote Similarity |
NPD9103 |
Approved |
0.646 |
Remote Similarity |
NPD9102 |
Approved |
0.6418 |
Remote Similarity |
NPD300 |
Approved |
0.6397 |
Remote Similarity |
NPD248 |
Discontinued |
0.6397 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.6391 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6385 |
Remote Similarity |
NPD9289 |
Approved |
0.6385 |
Remote Similarity |
NPD76 |
Approved |
0.6385 |
Remote Similarity |
NPD9288 |
Approved |
0.6385 |
Remote Similarity |
NPD9292 |
Approved |
0.6351 |
Remote Similarity |
NPD353 |
Discontinued |
0.635 |
Remote Similarity |
NPD282 |
Approved |
0.635 |
Remote Similarity |
NPD9650 |
Phase 3 |
0.6343 |
Remote Similarity |
NPD281 |
Approved |
0.6324 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6316 |
Remote Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.629 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD1128 |
Approved |
0.625 |
Remote Similarity |
NPD1127 |
Approved |
0.619 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6186 |
Remote Similarity |
NPD9101 |
Discontinued |
0.6164 |
Remote Similarity |
NPD250 |
Approved |
0.6164 |
Remote Similarity |
NPD249 |
Approved |
0.6159 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.6159 |
Remote Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.6144 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.6138 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.6131 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.6131 |
Remote Similarity |
NPD1356 |
Approved |
0.6131 |
Remote Similarity |
NPD1354 |
Approved |
0.6127 |
Remote Similarity |
NPD9133 |
Approved |
0.6111 |
Remote Similarity |
NPD1118 |
Discontinued |
0.6107 |
Remote Similarity |
NPD1368 |
Approved |
0.6103 |
Remote Similarity |
NPD4812 |
Phase 1 |
0.6099 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.6093 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6081 |
Remote Similarity |
NPD186 |
Discovery |
0.6081 |
Remote Similarity |
NPD195 |
Approved |
0.6067 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6061 |
Remote Similarity |
NPD578 |
Discontinued |
0.6053 |
Remote Similarity |
NPD214 |
Approved |
0.6053 |
Remote Similarity |
NPD213 |
Clinical (unspecified phase) |
0.6039 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6039 |
Remote Similarity |
NPD1732 |
Phase 3 |
0.6031 |
Remote Similarity |
NPD9132 |
Discontinued |
0.6029 |
Remote Similarity |
NPD78 |
Approved |
0.6029 |
Remote Similarity |
NPD9544 |
Approved |
0.6027 |
Remote Similarity |
NPD185 |
Approved |
0.6027 |
Remote Similarity |
NPD1451 |
Approved |
0.6014 |
Remote Similarity |
NPD9628 |
Approved |
0.6014 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6 |
Remote Similarity |
NPD193 |
Suspended |
0.6 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.5987 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.5986 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.5985 |
Remote Similarity |
NPD8833 |
Approved |
0.5985 |
Remote Similarity |
NPD8831 |
Approved |
0.597 |
Remote Similarity |
NPD9290 |
Approved |
0.5969 |
Remote Similarity |
NPD9412 |
Discontinued |
0.5954 |
Remote Similarity |
NPD757 |
Phase 3 |
0.5948 |
Remote Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.5946 |
Remote Similarity |
NPD166 |
Approved |
0.5935 |
Remote Similarity |
NPD219 |
Phase 3 |
0.5935 |
Remote Similarity |
NPD218 |
Approved |
0.5935 |
Remote Similarity |
NPD217 |
Approved |
0.5935 |
Remote Similarity |
NPD220 |
Clinical (unspecified phase) |
0.5935 |
Remote Similarity |
NPD216 |
Approved |
0.5935 |
Remote Similarity |
NPD3697 |
Discontinued |
0.5921 |
Remote Similarity |
NPD283 |
Approved |
0.5918 |
Remote Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.5874 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.5847 |
Remote Similarity |
NPD8835 |
Approved |
0.5844 |
Remote Similarity |
NPD242 |
Approved |
0.5844 |
Remote Similarity |
NPD3107 |
Discontinued |
0.5844 |
Remote Similarity |
NPD338 |
Approved |
0.5839 |
Remote Similarity |
NPD9627 |
Approved |
0.5827 |
Remote Similarity |
NPD9345 |
Clinical (unspecified phase) |
0.5823 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.5806 |
Remote Similarity |
NPD339 |
Approved |
0.5806 |
Remote Similarity |
NPD2180 |
Approved |
0.5789 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.5782 |
Remote Similarity |
NPD3695 |
Approved |
0.5782 |
Remote Similarity |
NPD3696 |
Approved |
0.5778 |
Remote Similarity |
NPD580 |
Discontinued |
0.5769 |
Remote Similarity |
NPD169 |
Phase 2 |
0.5748 |
Remote Similarity |
NPD9195 |
Approved |
0.5745 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.5738 |
Remote Similarity |
NPD9190 |
Approved |
0.5733 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.5732 |
Remote Similarity |
NPD2604 |
Approved |
0.5732 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD9086 |
Approved |
0.5693 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.5683 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.5683 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.5683 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.5682 |
Remote Similarity |
NPD9359 |
Approved |
0.5682 |
Remote Similarity |
NPD9358 |
Approved |
0.568 |
Remote Similarity |
NPD9134 |
Approved |
0.568 |
Remote Similarity |
NPD9135 |
Approved |
0.568 |
Remote Similarity |
NPD9255 |
Phase 2 |
0.5679 |
Remote Similarity |
NPD1777 |
Approved |
0.5679 |
Remote Similarity |
NPD1776 |
Approved |
0.5679 |
Remote Similarity |
NPD705 |
Clinical (unspecified phase) |
0.5679 |
Remote Similarity |
NPD247 |
Clinical (unspecified phase) |
0.5667 |
Remote Similarity |
NPD4240 |
Approved |
0.5664 |
Remote Similarity |
NPD8185 |
Discontinued |
0.5664 |
Remote Similarity |
NPD8186 |
Phase 1 |
0.5629 |
Remote Similarity |
NPD171 |
Discontinued |
0.5616 |
Remote Similarity |
NPD535 |
Approved |
0.5603
|
Remote Similarity |
NPD9366 |
Approved |